Fundraising Fox

AccuVein

Cold Spring Harbor, US · Delaware corporation · 2 known investors

Find your way into AccuVein

44 people in our graph share verified history with the AccuVein team — schools, employers, funds. One of them is your warm intro.

Richard Heymanunlockedknows Chris Hutchison · together at University of Minnesota (overlapped)

×7knows the team · via University of Minnesota

×2knows the team · via AccuVein

knows the team · via Cheetah Medical

knows the team · via Medical Graphics Corporation

AccuVein manufactures vein visualization systems for medical professionals to locate veins during procedures. The company serves healthcare providers in clinical and procedural settings.

Hardware Healthtech Medical Devices

Founders & leadership

RG

Ron Goldman

Ron GoldmaninCEO & President2007–2020

CH

Chris Hutchison

Chris Hutchison inPresident & CEOChris Hutchison is President and CEO of AccuVein, which manufactures vein visualization systems for medical professionals. He has held general management positions with international scope across the U.S., Europe, and emerging markets, including leading large-scale divestiture and integration projects.

Board

JL

James LackieBoard director

EB

Eric Bednarski

Eric BednarskiBoard directorPartner at MVM Life Science Partners

FF

Frank Flaut IIIBoard director

CG

Christopher GabrieliBoard director

Investors · 2

Bessemer Venture PartnersreportedRedwood City · $5M – $100M

MVM Life Science Partnersreported · 2 sourcesLondon · $20M – $100Mvia Stephen Reeders · board

Reported raises · per SEC filings

Form D private placements

$40.5M disclosed across 7 rounds · 2016–2023

▶$5.3MraisedFeb 2023 · 25 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Heather RohanDirector
Brian VerrierDirector
Kevin McArdleExecutive Officer
Christopher HutchisonExecutive Officer, Director
Akhilesh PathipatiDirector
Stephen ReedersDirector
James LackieDirector

Offering amount: $5.4M
Amount sold: $5.3M
First sale: Jan 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$17.3MraisedApr 2022 · 36 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Akhilesh PathipatiDirector
Brian VerrierDirector
Stephen ReedersDirector
James LackieDirector
Christopher HutchisonExecutive Officer, Director
Heather RohanDirector
Kevin McArdleExecutive Officer

Offering amount: $18.3M
Amount sold: $17.3M
First sale: Jul 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.5MraisedMay 2020 · 33 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Chuck JohnsonExecutive Officer
James LackieDirector
Christopher GabrieliDirector
Rudy MazzochiDirector
Ron GoldmanExecutive Officer, Director
Hugo HarrodDirector

Offering amount: $2.5M
Amount sold: $2.5M
First sale: Apr 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedNov 2019 · 33 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Christopher GabrieliDirector
Chuck JohnsonExecutive Officer
Ron GoldmanExecutive Officer, Director
James LackieDirector
Rudy MazzochiDirector
Hugo HarrodDirector

Offering amount: $2.1M
Amount sold: $2M
First sale: Oct 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$8MraisedFeb 2018 · 40 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Hugo HarrodDirector
Christopher GabrieliDirector
James LackieDirector
Ron GoldmanExecutive Officer, Director

Offering amount: $10M
Amount sold: $8M
First sale: Jan 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.9MraisedJan 2018 · 11 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

James LackieDirector
Ron GoldmanExecutive Officer, Director
Frank Flaunt IIIDirector
Christopher GabrieliDirector
Hugo HarrodDirector

Offering amount: $2.9M
Amount sold: $2.9M
First sale: Sep 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.5MraisedDec 2016 · 28 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

James LackieDirector
Eric BednarskiDirector
Frank Flaut IIIDirector
Ron GoldmanExecutive Officer, Director
Christopher GabrieliDirector

Offering amount: $9.1M
Amount sold: $2.5M
First sale: Nov 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

ivWatch90 shared keywordsivWatch develops sensors and monitoring systems that detect peripheral IV infiltrations and extravasations at early stages to prevent patient harm in hospital settings. The company serves healthcare providers and hospitals globally through direct partnerships and a network of distributors.

Companies competing with AccuVein for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

AccuVein Secures $22.5M in Series B Financing - FinSMEsfinsmes.com · Jul 2011

AccuVein Raises $23M In VC Funding Round | Institutional Investorinstitutionalinvestor.com · Jul 2011

Frequently asked questions

What does AccuVein do?: AccuVein manufactures vein visualization systems for medical professionals to locate veins during procedures. The company serves healthcare providers in clinical and procedural settings.
Who are AccuVein's investors?: AccuVein's investors include Bessemer Venture Partners, MVM Life Science Partners.
How much funding has AccuVein raised?: AccuVein has disclosed $40.5M raised across 7 rounds.
Where is AccuVein headquartered?: AccuVein is headquartered in Cold Spring Harbor, US.